Calidi Biotherapeutics (CLDI) Institutional Ownership $0.76 -0.24 (-23.85%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$0.72 -0.04 (-5.13%) As of 07/11/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Calidi Biotherapeutics (NYSE:CLDI)CurrentInstitutional OwnershipPercentage12.53%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$2.68MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$678.90K Get CLDI Insider Trade Alerts Want to know when executives and insiders are buying or selling Calidi Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CLDI Institutional Buying and Selling by Quarter Calidi Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2025Belpointe Asset Management LLC249,833$141K0.0%N/A0.878% 5/15/2025Armistice Capital LLC3,322,000$1.88M0.0%N/A11.669% 5/7/2025Drive Wealth Management LLC55,000$31K0.0%-38.9%0.193% 2/17/2025Millennium Management LLC136,137$157K0.0%+35.5%0.515% 2/14/2025Jane Street Group LLC33,437$38K0.0%N/A0.126% 2/12/2025Geode Capital Management LLC160,018$184K0.0%+304.0%0.605% 2/11/2025Virtu Financial LLC73,448$84K0.0%N/A0.278% 2/10/2025RS Crum Inc.40,463$47K0.0%N/A0.153% 2/7/2025HighTower Advisors LLC102,276$118K0.0%N/A0.386% 2/3/2025Red Wave Investments LLC80,828$93K0.0%+74.0%0.305% 1/22/2025Drive Wealth Management LLC90,000$104K0.0%N/A0.340% 1/14/2025CPR Investments Inc.101,000$116K0.1%+80.4%0.772% 11/15/2024Red Wave Investments LLC46,461$53K0.0%-92.6%0.418% 8/15/2024Delta Investment Management LLC210,230$42K0.0%+1,955.0%0.413% 8/8/2024RS Crum Inc.263,470$53K0.0%+2,327.4%0.517% 7/19/2024CPR Investments Inc.560,000$112K0.1%+700.0%11.002% 5/16/2024Apollo Management Holdings L.P.125,000$71K0.0%N/A0.352% 5/15/2024Magnetar Financial LLC63,132$36K0.0%N/A0.178% 5/14/2024Evermay Wealth Management LLC63,416$36K0.0%N/A0.178% 4/23/2024Spectrum Asset Management Inc. NB CA 166,494$94K0.0%N/A0.468% (Data available from 1/1/2016 forward) CLDI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLDI shares? During the previous two years, 16 institutional investors and hedge funds held shares of Calidi Biotherapeutics. The most heavily invested institutionals were Armistice Capital LLC ($1.88M), Geode Capital Management LLC ($184K), Millennium Management LLC ($157K), Belpointe Asset Management LLC ($141K), HighTower Advisors LLC ($118K), CPR Investments Inc. ($116K), and Spectrum Asset Management Inc. NB CA ($94K).Learn more on Calidi Biotherapeutics' institutional investors. What percentage of Calidi Biotherapeutics' stock is owned by institutional investors? 12.53% of Calidi Biotherapeutics' stock is owned by institutional investors. Learn more on CLDI's institutional investor holdings. Which institutional investors have been buying Calidi Biotherapeutics' stock? Of the 16 institutional investors that purchased Calidi Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($3.32M), CPR Investments Inc. ($535K), RS Crum Inc. ($293.08K), Belpointe Asset Management LLC ($249.83K), Delta Investment Management LLC ($200K), Spectrum Asset Management Inc. NB CA ($166.49K), and Apollo Management Holdings L.P. ($125K). How much institutional buying is happening at Calidi Biotherapeutics? Institutional investors have bought a total of 5,089,483 shares in the last 24 months. This purchase volume represents approximately $2.68M in transactions. Which of Calidi Biotherapeutics' major shareholders have been selling company stock? The following institutional investors have sold Calidi Biotherapeutics stock in the last 24 months: Red Wave Investments LLC ($578.14K), and Drive Wealth Management LLC ($35K). How much institutional selling is happening at Calidi Biotherapeutics? Institutional investors have sold a total of 613,141 shares in the last 24 months. This volume of shares sold represents approximately $678.90K in transactions. Related Companies Oramed Pharmaceuticals Institutional Ownership Adagene Institutional Ownership ImmunoPrecise Antibodies Institutional Ownership Metagenomi Institutional Ownership Cabaletta Bio Institutional Ownership Pliant Therapeutics Institutional Ownership Entera Bio Institutional Ownership Forte Biosciences Institutional Ownership IGM Biosciences Institutional Ownership ABVC BioPharma Institutional Ownership This page (NYSE:CLDI) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredDid you miss out on Trump’s “birthday gift” to Americans?While protestors were rallying against “King Trump,” one trader quietly spotted a 15% weekend move tied to his...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calidi Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calidi Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLDI Stock Alerts